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Genes encoding phosphofructokmases (PFK) from EsclzencIzzn coil and From the human muscle were expressed in PFK-deficient strains of 
Saccharonz~es cerevtstae under the control of an mducihle GALI promoter. They restored PFK actlvlty under inducing conditions and comple- 
mented the galactose-negative growth phenotype of the recipient strains. The PFK enzymes expressed appear to be stable in yeast. The human 
muscle enzyme crossreacts with specific antIbodIes and shows the expected subunlt size. .As expected. Its actlvlty can be activated by fructose-Z,& 
bisphosphate. m contrast to the bacterial enzyme. 
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1. INTRODUCTION 
Glycolysis is a major pathway for carbohydrate utili- 
zation in most organisms and is especially well estab- 
lished in the yeast Sffc~~~~~~~~e~ ecr visitae {see [I ] for 
a recent review). The phosphofructokinase (PFK) reac- 
tion, converting fructose-6-phosphate with ATP con- 
sumption to fructose-1.6-bisphosphate, is generally as- 
sumed to be a key controlling step in this pathway 121. 
In yeast, PFK is a heterooctameric enzyme, com- 
posed of 4a- and 4/?-subunits 131, which are encoded by 
PFKI and PFK?, respectively [4]. PFK activity is allo- 
sterically controlled by a variety of effecters (21 listed 
in [5]). The most potent activator of eukaryotic PFK’s 
is fructose-2,6-biphosphate discovered by van Schaftin- 
gen et al. [6] and shown to be also an activator of yeast 
PFK [7]. Genetic characterization in yeast gave the puz- 
zling result that nullmutants in any one of the PFK 
genes do not show in vitro detectable PFK activity but 
do grow on and ferment glucose [4], Only double mu- 
tants (PJkl pfxli?) are glucose-negative. Of the different 
hypotheses to explain this phenotype (summarized in 
[S]) only two remain valid: (i) The PFK-subunits serve 
a yeast-specific function in a ‘bypass’ reaction to glyco- 
lysis, or (ii) each of the subunits catalyzes the PFK- 
reaction in vivo by an activity that escapes detection in 
vitro. The latter could be due to an unstability of com- 
plexes formed by the remaining subunits upon dilution 
in the preparation of crude extracts. 
In this context, we have started an investigation of 
heterologous expression of PFK-genes from other or- 
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ganisms in S. cerevisiae. We have already expressed the 
two genes encoding the PFK subunits of the closely 
related yeast Kluyveromyces lactis [9]. There, the en- 
zyme is also functional only in the heteromeric state (i.e. 
mutations in any one of the genes leads to a loss of 
detectable PFK activity). Each of the genes is able to 
complement a S. cerevisiae pfl-double mutant for 
growth on glucose but does not restore in vitro measur- 
able enzymatic activity. However, a yeast-specific func- 
tion of PFK subunits cannot be excluded from these 
data, as the deduced amino acid sequences are more 
than 70% identical and could have retained such a func- 
tion. 
In most organisms studied, PFK is active as a ho- 
motetrameric enzyme. Thus, Escerichia coli contains 
two homotetrameri~ isoenzymes, with PFKA constitut- 
ing about 90% of the cellular activity [lo]. The PFK 
subunits of both enzymes are about half the size of those 
of mammalian and yeast PFK. leading to the hypothesis 
of an evolution by gene duplication events 111,121. The 
PFK enzymes of E. coli and Bacillus stearothermophilus 
are comparatively well studied in terms of X-ray crystal- 
lographic analysis [13] and in vitro mutagenesis of cru- 
cial amino acid residues [14-161. Amino acid residues 
determined as functional in these studies are generally 
conserved in eukaryotic PFK’s sequenced so far [9,11]. 
Mammalian PFK has drawn major attention because 
glycogen storage disease VII (Tarui’s disease) was found 
to be associated with a lack of muscle PFK activity [17]. 
Three kinds of subunits have been reported for mam- 
malian PFK, with homo- and heterotetrameric forms 
being active and being present in different amounts in 
different tissues [18,191. cDNA clones of human muscle 
PFK (hmPFK) have been isolated 120,211 and the ge- 
netic defect has been attributed in two cases to point 
mutations leading to defective splicing products [22,23]. 
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In this work I describe the expression of E. coli PFKA 
and hmPFK in a pjkl pfi2 double-null mutant of S. 
cererisiue. The data are used to address the question of 
a specific function of the yeast PFK-subunits (see 
above). In addition, this work provides the basis for the 
investigation of human (defective) PFK genes in a sim- 
ple. genetically well defined yeast system. 
2. EXPERIMENTAL 
3.1. Strums und medtu 
The yeast strams HDlOO-2A (MATu pfkl HIS3 pjl2 HIS3 hu3- 
II,15 uru3-517 trpl GAL) and HD114-16A (MAZ pjkl HIS3 
pfi2 HIS3 h1s3-11.15 uru3-52 lru2-3.112 MAL SW GAL) were used 
as rectpient strains for heterologous PFK gene expression. Both yeast 
strams were constructed durmg thts work. HDlOO-2A dertved from 
a number of crosses startmg with the strams AMW-13C’ (ortgmally 
a gift from M. Whiteway) and SMC-19A (from F.K Zimmermann). 
HDI 14-16A is a haplotd strain and. except for the delettons m /?fi 
genes. isogemcally derived from the dtplotd strain MC99 (kindly pro- 
vided by M. Ctrtacy) They were grown m rich media (1% yeast 
extract. 2% bacto peptone, 2% glycerol and 2% ethanol: YEPGE) for 
the preparation of competent cells. Synthettc mimmal medta were 
based on 0.67% yeast mtrogen base w/o amino acids, supplemented 
with amino acids and ademne as described m [24]. As carbon sources 
2% glucose (SCD). 2% g&lactose (SCGal) or 2% glycerol plus 2% 
ethanol (SCGE) were added. Solid media were prepared by the addi- 
tton of 2% oxotd agar. Cells were always incubated at 30°C. wtth 
constant shaking where hqutd media were employed 
Standard molecular procedures were used in handling of DNA [25] 
Yeasts were transformed wtth a modification of the freeze-method 
described by Klebe et al. [26,27]. E co11 stram DHSaF (Gibco/BRLl 
was used throughout and competent cells were prepared accordmg to 
[38] Plasmtd DNA was prepared from E toll with the ktt of Qutagen 
(Dusseldorf) accordmg to the mstructtons of the manufacturer 
Sequencing was based on the dideoxy-cham-termination method of 
Sanger et al. [29] using the USB sequenase kit accordmg to the mstruc- 
ttons of the manufacturer. The custom-made ohgonucleotide 5’- 
CTGCATAACCACTTTAAC-3’ was used as a sequencmg primer to 
determine the sequence around the G.l Ll fuston pomts. 
For expression m yeast, plasmtd pBM272 was used. It is a dertvative 
of pBM150 [30]. where a HmdIII-lmker was inserted mto the unique 
&mzHI sate, without destroymg the latter. Pchpfkml. carrying a 
cDNA clone of the human muscle PFK in pUC13. was kindly pro- 
vided by A McLachlan (La Jolla/Cahforma). The EcoRV fragment 
from thts vector carrymg the enttre gene and some polylmker se- 
quences. was subcloned mto pUK1921 [31] to yield pJJH50. From 
there, the f3amHI/Sp/rI fragment was isolated and cloned mto pBM272 
opened wtth the same restrtctton enzymes to give pJJH54. For con- 
struction of a fusion directly at the ATG translatton start codon. the 
oligonucleottde 5’-GAGTGGATCCATGACCCATGAAGAGC-3’ 
was used m conJunction wtth the reverse sequencing prtmer to amplify 
the hmPFK gene from pJJH50 by PCR accordmg to the protocol1 of 
Perkin-Elmer. The resulting fragment was isolated from an agarose gel 
and dtgested with BuIJ~HI and cloned into pBM272 linearized wtth 
BufnHI to gave pJJH55. The clone wtth the E toll PFKA gene con- 
tamed within a BurnHI fragment. pHL1. was a gtft from P Evans 
(Cambrtdge. UK). 
For determmation of specific PFK acttvtttes, crude extracts were 
prepared with glass beads as described earlier [32]. Protem concentra- 
tions m crude extracts were determined by the method of Zdmenhof 
[33]. using bovme serum albumin as a standard. For routine determt- 
nations of PFK activtties. 0.1 M potassium phosphate buffer at pH 
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7.0 was used The testmtx contained 5 mM magnesium chloride, 1 mM 
ATP. 0.3 mM ADP. 0.1 mM AMP. 0.25 mM NADH and 3 mM 
fructose-6-phosphate at final concentrattons. The decrease m absorp- 
tion at 340 nm was followed for 3 mtn prior to the addition ofsubstrate 
and for 15 mm m the presence of fructose-6-phosphate The tests were 
carried out m a Beckmann DU700tJ spectrophotometer at a constant 
temperature of 30°C 
To determine the acttvatory effect of fructose-2.6-btsphosphate. 50 
mM MES-buffer at pH 6.4 was used, ADP and AMP were omitted 
from the testmix, the ATP concentratton was raised to 3 mM and the 
fructose-6-phosphate concentration was lowered to 1.5 mM. 100 PM 
fructose-2.6-btsphosphate was added where Indicated. 
For immunoblot analysis, samples contammg 3Opg of crude extract 
protein were apphed to 7.54 SDS-polyacrylamide gels. Western blots 
were carrted out as described by Zachariae et al [34] usmg a 1200 
dilution of mammalian PFK-anttserum obtained from rabbits kmdly 
provided by G Dunaway (Springfield, Illmois) and a 1:400 dilution 
of an actm-anttbody raised in mouse. purchased from Boehrmger. 
Mannheim Anti-rabbit and anti-mouse secondary antibodies coupled 
to alkaline phosphatase were purchased from Sigma 
3. RESULTS AND DISCUSSION 
3.1. Construction qf expression plusmirEs 
Heterologous PFK-genes may not be expressed in 
yeast under the control of their own promoters. In addi- 
tion, some proteins may have a deleterious effect when 
expressed in the yeast cell in high amounts. Therefore, 
the gene from E. coli (EcPFKA: from pHL1 described 
in [35]) and a cDNA-clone containing the human mus- 
cle PFK gene (hmPFK; [21]) were cloned into the vector 
pBM272 (see section 3) under the control of the GALZ- 
promoter as shown in Fig. 1. For this purpose, the 
BarnHI fragment of pHL1 was inserted into the single 
&zrlzHI site of pBM372 to yield pJJH40. The correct 
orientation was verified by restriction and sequence 
analyses. Only 5 bp of the original 5’-noncoding se- 
quence of EcPFKA remained in front of the ATG trans- 
lation start codon. 
For subcloning of hrnPFK, first convenient EcoRV 
sites of the clone provided were used (see section 2) to 
yield pJJH54. This clone contains 76 bp of the 5’-non- 
coding region of the originally isolated cDNA clone as 
well as some polylinker sequences between the GAL1 
promoter and the translation start codon. As this region 
seems to interfere with expression in yeast (see below). 
a fragment starting at the ATG codon was amplified by 
a PCR approach (see section 2) and cloned into 
pBM272 (pJJH55; Fig. 1). 
3.2. Phenotypes upon expression in u Iyeast pfkl pfk2 
double-null mutant 
The three plasmids constructed as well as the vector 
without a PFK insertion were transformed into the 
strains HD 1 OO-2A and HD 114-16A. carrying deletions 
in the two yeast PFK genes. The recipient strains are 
unable to grow on glucose or galactose as sole carbon 
sources, due to the block in the glycolytic pathway. 
Consequently, transformants were selected on SCGE 
lacking uracil. Three clones obtained from each plasmid 
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GAL7 BarnHI EcPFKA EarnHI 
ATG 
ii\ 
y/;/j 
GGATCCCTTCG 
GAL? BamHi hmPFK Sphl 
GGATCC-20 bp-CGGGCGGGCCTCCCCCC-65 ba 
pJJH40 
pJJH54 
GAL1 Bamtil 
ATG 
hmPFK Barn/+ 
V//l pJJH55 
Fig. 1, Expression constructs for heterologous PFK genes The genes were cloned into convenient restriction sites of the vector pBM272 shour;n 
in the upper part (see text for details). In the lower part of the figure, the black arrows Indicate the GAL1 promoter (816 bp), the black boxes 
S-noncoding sequences of the heterologous PFK genes retained m cloning (with sequences mdlcated below). Open boxes starting with the ATG 
translation start codon designate the open reading frames and boxes with a right slant show the 3’-noncodmg sequences retamed from the orlginal 
clones. 
were picked and tested for their ability to grow on media 
with glucose or galactose as sole carbon sources {Fig. 
2). As expected, all of the transformants were glucose- 
negative. On galactose, only transformants with 
pJJH40 (EcPFKAf and pJJH55 (hmPFK) were able to 
grow. In liquid medium without uracil and 2% galactose 
they grew with generation times of 2.5 to 3 h as com- 
pared to 2 h of an isogenic, untransformed strain being 
37 
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Ftg. 2. Growth of transformants on different carbon sources Three Independent transformants of strain HDlOO-2A @Jcl~~HIS3pfkz .HIS3) wtth 
the plasmids Indicated (compare Fig. 1) were streaked onto SCGE. left to grow and replica-plated onto synthetic medta wtth the Indicated carbon 
sources lacking uractl They were incubated for 3 days at 30°C. Residual growth on galactose medmm of transformants with pBM272 and pJJH54 
can be attrtbuted to less stringent carbon catabohte represston exerted by this carbon source as compared to glucose. No restdual growth can be 
observed upon platmg again on galactose or streaking out for smgle colomes. 
wild-type for the yeast PFK genes with the addition of 
uracil. A single pjk2 deletion mutant grows with a gen- 
eration time of 3 h under these conditions. 
From this growth behaviour, one can conclude that 
both EcPFKA and hmPFK can be expressed in yeast to 
the extent of complementing the galactose-negative phe- 
notype. Furthermore, the S-noncoding sequences in 
pJJH54 originating from the human cDNA clone and 
polylinker sequences seem to prevent a level of expres- 
sion necessary for complementation. This may be attri- 
buted to an extremely CC-rich region from -65 to -81 
bp relative to the translation start codon (Fig. 1) that 
may interfere with efficient translation [36]. 
Transformants with pJJH40 (EcPFKA) and pJJH55 
(hmPFK) had restored PFK activity in crude extracts 
(Fig. 3A and B). Thus, PFK activities were about 50% 
higher in transformants with pJJH40 (EcPFKA; 480 
mU/mg protein) as compared to those of an isogenic 
strain being wild-type for the yeast PFK genes (305 
mU/mg protein). On the other hand, transformants with 
pJJH55 (hmPFK, 140 mU/mg protein) showed less than 
50% of the activity of the wildtype control. These data 
indicate, that both heterologous PFK genes can be func- 
tionally expressed in yeast. 
Further evidence that the PFK activities observed are 
due to the expression from the transformed plasmids 
was obtained by shifting cells from galactose to glucose 
media (Fig. 3A). Upon such a shift, specific PFK activ- 
ities decreased to less than 10% within 24 h of incuba- 
tion. This reduction can be largely attributed to the 
dilution of intracellular PFK during growth, rather 
than to degradation of the protein. In cultures left to 
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grow to stationary phase on galactose medium. more 
than 60% of the initial PFK activity was retained in 
both types of transformants in the same period. The 
reduction after 24 h of incubation can be attributed to 
the consumption of galactose from the medium and the 
consequent decrease in GAL1 promoter activity. When 
glucose was added to stationary phase cells expressing 
the heterologous PFK’s, more than 60% of the initial 
PFK-activity was retained even after 24 h of incubation, 
indicating that the proteins are very stable. Vice versa. 
galactose addition to cells pregrown well into stationary 
phase on galactose and shifted overnight onto SCGE 
lacking uracil resulted in induction of PFK activity (Fig. 
3B). For transformants with pJJH55 (IzmPFK) the in- 
crease in PFK-activity was shown to be accompanied by 
an increase in the amount of protein in a Western blot 
(Fig. 3C). The crossreactivity with the antiserum and 
the size of the band indicate that the correct subunits are 
produced in yeast. 
3.3. Effect of fructose-2.bbisphosphate 
Eukaryotic PFK enzymes are allosterically activated 
by fructose-2,6-bisphosphate, whereas prokaryotic en- 
zymes do not respond to the presence of this compound 
[37]. This holds true for the enzymes expressed in S. 
cerevisiae. Whereas the specific PFK activities in crude 
extracts from transformants with pJJH40 (EcPFK) did 
not vary significantly upon addition of the activator 
(247 mU/mg protein and 265 mU/mg protein without 
and with fructose-2,6-bisphosphate, respectively), they 
increased by a factor of 34 in those from transformants 
with pJJH55 (hmPFK; 22 mU/mg protein and 70 mU/ 
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Fig. 3. Control of PFK-expression by the carbon source. Strain 
HDI 14-16A (pfkl::HIS3 pfk2,:HIsS) transformed with the plasmids 
Indicated (compare Fig. 1) was used to prepare crude extracts after the 
followmg incubattons. (A) Cells were grown m 50 ml SCGal to early 
stationary phase, washed once with sterile water and inoculated in 
fresh SCGal (Gal) and SCD (Glc) at about half the ortginal cell density 
at time 0. At the time points indicated, samples of 8 ml were taken, 
washed twice and the cell pellet was frozen at -20°C until used for 
preparation of crude extracts and determmation of specific PFK activ- 
ities. (B) Cells were left to grow to stationary phase for 3 days in 100 
ml SCGal. 30 ml of each culture were used to inoculate 100 ml of fresh 
SCGE and incubated overmght At time 0 galactose was added to a 
final concentration of 2% and samples were taken and treated as 
described above. (C) Western blot with 30 pg of protein of the crude 
extracts prepared in (B) loaded in each lane. The apparent molecular 
weights of the stze standard are indicated. As a control. rabbtt muscle 
PFK obtained from Boehringer-Mannheim (rmPFK) was loaded in 
the leftmost lane. Transformants with pJJH40 (EcPFKA) were used 
as a negative control where the human PFK is not expressed. As a 
loadmg control, the blot was also probed with anti-actm antibodies 
as indicated. A band at about 58 kDa is not PFK-specific and repre- 
sents a yeast protein crossreacting with the mammalian antiserum. 
mg protein without and with the activator, respectively). 
Thus, the latter enzyme is not only folded correctly in 
its catalytic domains, but also retains its allosteric prop- 
erties. 
As both a prokaryotic and a eukaryotic PFK gene can 
be functionally expressed in the yeast S. cerevisiae, this 
work provides the basis for the study of mutant genes 
and their products in a simple eukaryotic system. In 
addition, it confirms that PFK functions are highly con- 
served through evolution. From the fact, that the pjk 
defect of the recipient strain can be phenotypically com- 
plemented, one can conclude that either the yeast PFK 
subunits do not serve a second function distinct from 
catalysis in hexose fermentation or that the heterolo- 
gous PFK proteins would also carry out such a func- 
tion. Taking into account that the E. co/i-PFK subunits 
are less than half-size of those of yeast and that the 
bacterial enzyme is in many ways differently regulated 
by effecters [38], the latter explanation seems highly 
improbable. 
Transformants with the E. coli PFKA gene did not 
show a significantly impaired growth defect on galac- 
tose medium as compared to wild-type yeast strains. 
The main allosteric effecters of yeast PFK activity 
under physiological conditions are ATP (inhibition) 
and fructose-3,6-bisphosphate (activation). Both com- 
pounds do not affect the activity of E. coli PFK [37,38]. 
Thus, the lack of these allosteric control mechanisms in 
the respective transformants does not seem to have a 
major phenotypic effect on the yeast cells. However, 
substitution by ohter regulatory factors (i.e. inhibition 
by elevated PEP concentrations and activation by ADP 
and ATP), to which the E. coli PFK is liable [38] cannot 
be excluded. Also, the regulatory differences between 
the yeast and the E. coli PFK could be relevant under 
other experimental conditions. In this context, we are 
in the process of subcloning the heterologous PFK genes 
under the control of a constitutive promoter to allow for 
growth on hexoses other than galactose. 
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